Top in endocrinology: Vegan vs. Mediterranean diet, approval of Lyumjev for pump therapy

Adopting a vegan diet could significantly lower the risks for CVD and other conditions, according to speakers at the Association of Diabetes Care and Education Specialists meeting.

During a presentation, Hana Kahleova, MD, PhD, MBA, and Meghan Jardine, MS, MBA, RND, LD, CDCES, both from the Physicians Committee for Responsible Medicine, compared the health benefits of vegetarian and vegan diets with other plant-based eating patterns, including the Mediterranean diet. A recap of their talk was the top story in endocrinology last week.

Another top story was about the FDA approval of Lyumjev (insulin lispro-aabc injection, Eli Lilly) for use in insulin pumps. Insulin lispro-aabc is a novel formulation of insulin lispro that is designed to speed the absorption of insulin into the bloodstream and reduce HbA1c.

Read these and more top stories in endocrinology below:

Vegan diet provides most health benefits among plant-based eating patterns

Vegetarian and vegan diets provide greater reductions in body weight, fat mass and LDL cholesterol and improved insulin sensitivity compared with other plant-based eating patterns, such as a Mediterranean diet, according to two speakers. Read more.

FDA approves faster-acting insulin lispro for pump therapy

The FDA approved an expanded label for rapid-acting insulin lispro-aabc injection to include administration via continuous subcutaneous infusion with an insulin pump, according to an industry press release. Read more.

Foods with high protein, saturated fatty acids linked to better thyroid function

Eating more foods that are high in protein and saturated fatty acids is associated with better thyroid function, according to findings from a cross-sectional study published in Nutrition. Read more.

Eye problems more common among children exposed to diabetes in utero

Mothers who develop diabetes before or during pregnancy are more likely to have children who develop refractive errors, according to findings published in Diabetologia. Read more.

Testosterone therapy may be safe for use in men with advanced prostate cancer

Testosterone therapy was not associated with unexpected or rapid disease progression in a cohort of men with biochemical recurrence or metastatic prostate cancer, according to study findings. Read more.